Connect to share and comment

In a cloning first, scientists create stem cells from adults

By Sharon Begley NEW YORK (Reuters) - Scientists have moved a step closer to the goal of creating stem cells perfectly matched to a patient's DNA in order to treat diseases, they announced on Thursday, creating patient-specific cell lines out of the skin cells of two adult men.

Japanese researcher stands by her disputed stem cell discovery

By Elaine Lies TOKYO (Reuters) - Fighting back tears, a Japanese researcher under fire for fabricating parts of scientific papers hailed as breakthroughs in stem cell research said on Wednesday she stood by her discovery and hoped it could still help the world.

Japan finds fraudulent steps in 'breakthrough' stem cell paper

By Kiyoshi Takenaka TOKYO (Reuters) - Japan's top research body on Tuesday accused the lead writer of stem cell papers hailed as a game-changer in the field of medical biology of misconduct involving fabrication, but the scientist called the findings unacceptable. Two papers published in the scientific journal Nature in January detailed simple ways to reprogram mature animal cells back to an embryonic-like state, allowing them to generate many types of tissues.

'Phony' stem cell research scientist to be punished in Japan

A Japanese research institute said Tuesday it will punish a young female scientist after a probe found a ground-breaking study on the production of stem cells was fabricated. Riken institute head, Ryoji Noyori, who jointly won the Nobel Prize for chemistry in 2001, said in a statement he will "rigorously punish relevant people after procedures in a disciplinary committee." The punishment is expected to be meted out to lead researcher Haruko Obokata and her more experienced colleagues.

Japan stem cell scientist calls for retraction of study

A co-author of a Japanese study that promised a revolutionary way to create stem cells has called for the headline-grabbing research to be retracted over claims its data was faulty. The findings, published by Japanese researcher Haruko Obokata and US-based scientists, outlined a simple and low-tech approach in the quest to grow transplant tissue in the lab. The study was touted as the third great advance in stem cells -- a futuristic field that aims to reverse Alzheimer's, cancer and other crippling or lethal diseases.

Stem cell scientist calls for retraction of study

A co-author of a Japanese study that promised a revolutionary way to create stem cells has called for the headline-grabbing research to be retracted over claims its data was faulty. The findings, published by Japanese researcher Haruko Obokata and US-based scientists, outlined a simple and low-tech approach in the quest to grow transplant tissue in the lab. The study was touted as the third great advance in stem cells -- a futuristic field that aims to reverse Alzheimer's, cancer and other crippling or lethal diseases.

Scientist urges withdrawal of his own 'breakthrough' stem cell research

By Kiyoshi Takenaka and Kate Kelland TOKYO/LONDON (Reuters) - A Japanese scientist called on Monday for his own headline-grabbing study on stem cells to be withdrawn from publication, saying its findings had now been thrown into too much doubt. The research - hailed when it came out in January as a breakthrough that could herald a new era of medical biology - was covered widely in Japan and across the world after it was published in the highly reputable science journal Nature.

Science sees future beyond Paralympics

Imagine a future with no sporting events for paralysed people. A future in which there is no need, as all the would-be competitors will have been cured. This scenario, laughable just a few decades ago, is no longer far-fetched, experts say. Bit by bit, important progress is being made in understanding and tackling aspects of paralysis.

Paralysis treatment: Leading avenues of research

Following are the main areas of research in paralysis treatment: - Cell therapy: Stem cells are immature cells that grow into the specialised cells that comprise the body's tissue. The aim is to coax these cells into becoming nerve cells to replenish those damaged in spinal injury. Hopes were battered in 2011 when Geron, a California-based pioneer, abandoned the field, citing high costs. Prospects have revived with Newark-based company StemCells Inc, which implants stem cells obtained from donated foetal brain tissue.

Cuba has used stem cells to treat over 5,000 patients

Havana, Feb 16 (EFE).- More than 5,000 patients have been treated with stem cells in Cuba since the procedure started being used on the island a decade ago, the official Granma newspaper said. "Cuba occupies an important place" in the use of the regenerative therapy in the region, with the procedure being used in 13 of the island's 15 provinces, the newspaper said. More than 60 percent of patients receiving the therapy, according to official figures from 2012, suffered from severe ischemia in the lower limbs and other angiological illnesses.
Syndicate content